Cellectis S.A.
CMVLF
$3.47
$0.3912.66%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -44.44% | -70.44% | |||
| Total Other Revenue | -2.15% | -9.14% | |||
| Total Revenue | -38.17% | -67.15% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -38.17% | -67.15% | |||
| SG&A Expenses | 16.41% | -7.80% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -119.69% | 307.79% | |||
| Total Operating Expenses | 10.68% | 1.49% | |||
| Operating Income | -45.05% | -315.78% | |||
| Income Before Tax | 33.74% | -4,640.07% | |||
| Income Tax Expenses | 110.87% | -- | |||
| Earnings from Continuing Operations | 32.50% | -4,568.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 32.50% | -4,568.25% | |||
| EBIT | -45.05% | -315.78% | |||
| EBITDA | -44.37% | -237.28% | |||
| EPS Basic | 32.63% | -4,545.76% | |||
| Normalized Basic EPS | 33.85% | -4,602.70% | |||
| EPS Diluted | 32.63% | -4,545.76% | |||
| Normalized Diluted EPS | 33.85% | -4,727.78% | |||
| Average Basic Shares Outstanding | 0.20% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.20% | -1.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||